| Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation (NCT05298930) | Centre Leon Berard | 2022-05-25 |
| Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) (NCT03597594) | St. Jude Children's Research Hospital | 2021-09-02 |
| Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency (NCT02860559) | Taiga Biotechnologies, Inc. | 2021-08-01 |
| Study Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow Allograft (NCT04246840) | Association Pour l'Aide a la Recherche en Immunologie Pediatrique | 2020-01-13 |
| A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts (NCT04331483) | Centre Leon Berard | 2018-12-08 |
| Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation (NCT03513328) | University of Florida | 2018-06-15 |
| Autologous Gene Therapy for Artemis-Deficient SCID (NCT03538899) | University of California, San Francisco | 2018-05-31 |
| Neonatal Screening of Severe Combined Immunodeficiencies (NCT02590328) | Children's Hospital of Fudan University | 2015-12-01 |
| Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China (NCT02231983) | Shanghai Children's Medical Center | 2014-09-01 |
| Sirolimus Prophylaxis for aGVHD in TME SCID (NCT02177760) | University of California, San Francisco | 2014-07-01 |
| EZN-2279 in Patients With ADA-SCID (NCT01420627) | Leadiant Biosciences, Inc. | 2014-01-24 |
| Immune Disorder HSCT Protocol (NCT01821781) | Washington University School of Medicine | 2013-04-29 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827) | Roswell Park Cancer Institute | 2012-02-28 |
| Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim (NCT01182675) | University of California, San Francisco | 2010-08-01 |
| Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector (NCT01129544) | David Williams | 2010-04-01 |
| Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population (NCT00845416) | University of California, San Francisco | 2009-03-01 |
| MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID (NCT00794508) | Donald B. Kohn, M.D. | 2008-11-01 |
| Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products (NCT00695279) | St. Jude Children's Research Hospital | 2007-01-04 |
| SCID Bu/Flu/ATG Study With T Cell Depletion (NCT02127892) | Neena Kapoor, M.D. | 2007-01-02 |
| Genetic Basis of Immunodeficiency (NCT00055172) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-04-05 |
| Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases (NCT01019876) | Columbia University | 2002-09-01 |
| Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients (NCT00220766) | Grifols Therapeutics LLC | 2002-08-01 |
| Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) (NCT00028236) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-12-10 |
| Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID (NCT00006335) | National Human Genome Research Institute (NHGRI) | 2000-09-26 |
| Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies (NCT00006054) | Fairview University Medical Center | 2000-03-01 |
| Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant (NCT00008450) | Fred Hutchinson Cancer Center | 1997-08-11 |
| Cord Blood Stem Cell Transplantation Study (COBLT) (NCT00000603) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency (NCT00228852) | Emory University | |
| Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts (NCT06731036) | University of Florida | |